Medical Devices Late Stage Investors & VC Firms
489 firms in this list, with a median first check of $1.1M. 105 of them lead rounds. Generated from verified public data and updated continuously.
FFG Venture Business Partners
FukuokaPre-Seed–Late Stage$1M – $50M
1 person
Zhejiang Sino Wisdom Investment Co.,Ltd.
HangzhouSeries A–Late Stage
5 people
Hiventures
BudapestSeed–Late Stage$43.2K – $43.2M
2 people
Longbow Capital LLP
NorwichSeries C–Late Stage$1.3M – $12.7M
2 people
ICICI Venture
MumbaiGrowth–Late Stage$500K – $2.5M
1 person
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
Technology Venture Partners
MinneapolisSeed–Late Stage
3 people
City Side Ventures LLC
BirminghamSeed–Late Stage$150K – $10M
1 person
Cutlass Capital, L.L.C.
BostonSeed–Late Stage$3M – $7M
1 person
Kenson Ventures, LLC
Menlo ParkSeed–Late Stage$500K – $3M
1 person
Advantech Capital
Camana BayGrowth–Late Stage
3 people
Company K Partners
SeoulSeed–Late Stage$2.2M – $44M
GVFL Ltd.
AhmedabadSeed–Late Stage$250K – $25M
Ameba Capital
ShanghaiSeed–Late Stage
3 people
ePlanet Capital
San JoseSeed–Late Stage
3 people
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
BrightEdge
AtlantaSeed–Late Stage
2 people
Swiftarc Ventures
New YorkSeed–Late Stage
3 people
CBC Group
SingaporeSeed–Late Stage
2 people
Wellcome Trust
LondonSeed–Late Stage
BSK Investment
SeoulSeed–Late Stage
2 people
Hanne Capital
ShanghaiSeed–Late Stage
2 people
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
Related lists
Late Stage Investors & VC Firms (2974)Late Stage Investors & VC Firms in North America (1695)Late Stage Investors & VC Firms in United States (1516)Medical Devices Investors & VC Firms (1452)Medical Devices Seed Investors & VC Firms (1202)Medical Devices Series A Investors & VC Firms (1187)Late Stage Investors & VC Firms in Europe (965)Medical Devices Investors & VC Firms in North America (948)Healthtech Late Stage Investors & VC Firms (925)Late Stage Investors & VC Firms in Global (904)
Data sourced from public filings and firms' own websites — see our methodology.













